Name | NANOMED, OOO |
|---|
INN | 5837044394 |
|---|
KPP | 583701001 |
|---|
OGRN | 1105837002204 |
|---|
OKPO | 66708887 |
|---|
Address | 440068, Penzenskaya Oblast', g. Penza, ul. Tsentral'naya, d. D.1 |
|---|
Phone | 90-01-70 Contact details |
|---|
Fax | 38-09-59 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 20.59 | Additional activity | Manufacture of other chemical products | | 25.73 | Additional activity | Manufacture of tools | | All types of activities | | 32.12.1 | Additional activity | Manufacture of jewelry, gold and silversmiths' wares (except imitation jewelry) | | 32.50 | Additional activity | Dental Laboratories | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 86.90 | Additional activity | Activities in the field of medicine other |
Registration date | 06.09.2010 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po Pervomayskomu rayonu g.Penzy |
|---|
|
NANOMED, OOO (Penza Oblast; INN 5837044394) was registered on 6 Sep 2010. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of NANOMED, OOO - Limited liability companies. Form of ownership of NANOMED, OOO - Private property. Principal activities of NANOMED, OOO: research and experimental development on natural sciences and engineering other (72.19), manufacture of other chemical products (20.59), manufacture of tools (25.73). |
Economic indicators2023
Net loss (RAS) of NANOMED, OOO increased by 39.46% to 27.42 million RUB from 19.66 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 8.61% to 125.59 million RUB from 137.42 million RUB in 2022. 2022
Net loss (RAS) of NANOMED, OOO dropped over 2022 by 23.77% to 19.66 million RUB from 25.79 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 1.11% to 137.42 million RUB from 135.91 million RUB over 2021. 2021
Net loss (RA) of NANOMED, OOO made up 25.79 million RUB over 2021 compared to net profit of 9.20 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 8.10% to 135.91 million RUB from 147.90 million RUB in 2020. 2020
Net profit (RAS) of NANOMED, OOO dropped in 2020 by 15.22% to 9.20 million RUB from 10.85 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 9.38% to 147.90 million RUB from 135.21 million RUB over 2019. 2019
Net profit (RAS) of NANOMED, OOO dropped in 2019 2.56 times to 10.85 million RUB from 27.81 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 15.16% to 135.21 million RUB from 117.41 million RUB over 2018. 2018
Net profit (RAS) of NANOMED, OOO made up 27.81 million RUB over 2018 compared to net loss of 2.88 million RUB over 2017, the company informed. Revenue increased in the accounting period 1.56 times to 117.41 million RUB from 75.33 million RUB over 2017; cost of goods sold grew 1.53 times to 118.34 million RUB from 77.34 million RUB; sales loss decreased 2.16 times to 930.00 thousand RUB from 2.01 million RUB. 2017
Net loss (RA) of NANOMED, OOO made up 2.88 million RUB over 2017 compared to net profit of 10.56 million RUB over 2016, the company informed. Revenue increased in the accounting period 2.25 times to 75.33 million RUB from 33.45 million RUB over 2016; cost of goods sold grew 2.89 times to 77.34 million RUB from 26.77 million RUB; sales loss made up 2.01 million RUB compared to sales profit of 6.68 million RUB. 2016
Net profit (RAS) of NANOMED, OOO made up 10.56 million RUB over 2016 compared to net loss of 6.79 million RUB over 2015, the company informed. Revenue increased in the accounting period by 10.46% to 33.45 million RUB from 30.28 million RUB over 2015; cost of goods sold decreased by 26.40% to 26.77 million RUB from 36.37 million RUB; sales profit made up 6.68 million RUB compared to sales loss of 6.09 million RUB. 2014
Net loss (RA) of NanoMed, OOO made up 2.08 million RUB over 2014 compared to net profit of 47.29 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 39.67% to 76.91 million RUB from 127.48 million RUB in 2013; cost of goods sold decreased by 2.21% to 72.99 million RUB from 74.65 million RUB; sales loss made up 1.18 million RUB compared to sales profit of 48.89 million RUB. 2013
Net profit (RAS) of NanoMed, OOO made up 47.34 million RUB over 2013 compared to net loss of 3.00 million RUB over 2012, the company informed. Revenue increased in the accounting period 11.45 times to 127.48 million RUB from 11.14 million RUB over 2012; cost of goods sold grew 4.54 times to 78.60 million RUB from 17.32 million RUB; sales profit made up 48.89 million RUB compared to sales loss of 6.18 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|